DalsnaFinance › IPOs › Biohaven LTD › IPO

Biohaven Pharmaceutical Holding Co Ltd. IPO

Completed

Biohaven Pharmaceutical Holding Co Ltd. completed its initial public offering on NYSE on May 4, 2017, pricing at $17.00 a share.

Ticker	BHVN
Exchange	NYSE
Status	Completed
Listing date	May 4, 2017
Offering price	$17.00
Shares offered	9,900,000
Total raised	$168M

The offering

Biohaven Pharmaceutical Holding Co Ltd. sold 9,900,000 shares at $17.00 each on NYSE. Multiplied out, that is $168.3 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $168 million total recorded for the deal.

Company coverage

Biohaven Pharmaceutical Holding Co Ltd. — quote, profile and latest news →

Other recent IPOs

Iambic Therapeutics, Inc. · October 13, 2026
Retension Pharmaceuticals, Inc. · October 8, 2026
Frazier Life Sciences Acquisition Corp. II · October 8, 2026
TRex Bio, Inc. · October 6, 2026
Pine Tree Acquisition Corp. · October 5, 2026
Accelevation Holdings Corp. · September 30, 2026
Southport Acquisition Corp. II · September 30, 2026
ROZE AI INC. · September 28, 2026

Source: SEC EDGAR filings for Biohaven Pharmaceutical Holding Co Ltd.. This page is general information, not investment advice.